Holocene Advisors
THC icon

Holocene Advisors’s Tenet Healthcare THC Stock Holding History

Holocene Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,459
Closed -$3.11M – 1000
2026
Q1 		$3.11M Buy
+16,459
New +$3.47M 0.01% 493
2025
Q3 		– Sell
-584,404
Closed -$103M – 912
2025
Q2 		$103M Buy
+584,404
New +$88M 0.25% 106
2024
Q4 		– Sell
-257,642
Closed -$42.8M – 884
2024
Q3 		$42.8M Buy
257,642
+21,935
+9% +$3.32M 0.17% 168
2024
Q2 		$31.4M Sell
235,707
-89,656
-28% -$10.8M 0.13% 176
2024
Q1 		$34.2M Buy
+325,363
New +$29.2M 0.13% 180
2023
Q4 		– Sell
-33,468
Closed -$2.21M – 834
2023
Q3 		$2.21M Sell
33,468
-13,814
-29% -$1.03M 0.01% 543
2023
Q2 		$3.85M Buy
47,282
+12,465
+36% +$887K 0.02% 408
2023
Q1 		$2.07M Buy
+34,817
New +$1.94M 0.01% 455
2022
Q4 		– Sell
-7,918
Closed -$408K – 908
2022
Q3 		$408K Sell
7,918
-753,728
-99% -$44.7M ﹤0.01% 724
2022
Q2 		$40M Buy
761,646
+343,371
+82% +$23.9M 0.24% 125
2022
Q1 		$36M Buy
+418,275
New +$34.4M 0.19% 146
2020
Q2 		– Sell
-24,096
Closed -$347K – 778
2020
Q1 		$347K Sell
24,096
-76,563
-76% -$2.2M ﹤0.01% 595
2019
Q4 		$3.83M Buy
100,659
+57,294
+132% +$1.72M 0.03% 252
2019
Q3 		$959K Buy
+43,365
New +$924K 0.01% 501
2018
Q1 		– Sell
-19,107
Closed -$290K – 721
2017
Q4 		$290K Buy
+19,107
New +$269K 0.01% 552

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Holocene Advisors's THC Position: Q2 2026 in Review

Holocene Advisors sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 16,459 shares — an estimated $3.11M sold.

Holocene Advisors first reported a position in THC in Q4 2017 and held it in 15 quarters. The position peaked at $103M in Q2 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Holocene Advisors reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Holocene Advisors sold 16,459 Tenet Healthcare shares in Q2 2026, an estimated $3.11M.
  • Holocene Advisors first reported a position in Tenet Healthcare in Q4 2017 and held it in 15 quarters.
  • Holocene Advisors's Tenet Healthcare position peaked at $103M in Q2 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.